Presbyopia-correcting intraocular lenses in eyes with corneal conditions: an update.

IF 2.6 2区医学 Q1 OPHTHALMOLOGY

Current Opinion in Ophthalmology Pub Date : 2025-09-04 DOI:10.1097/ICU.0000000000001175

Richard N McNeely, Jonathan E Moore, Jodhbir S Mehta, Darren S J Ting

{"title":"Presbyopia-correcting intraocular lenses in eyes with corneal conditions: an update.","authors":"Richard N McNeely, Jonathan E Moore, Jodhbir S Mehta, Darren S J Ting","doi":"10.1097/ICU.0000000000001175","DOIUrl":null,"url":null,"abstract":"Purpose of review: Modern presbyopia-correcting intraocular lenses (IOLs) offer a potential solution to address the rising postoperative demand and expectations for spectacle independence following cataract surgery. However, IOL calculation and selection becomes more complex when presented with previous corneal refractive surgery (CRS) or co-existing corneal conditions. This review explores the use of presbyopia-correcting IOLs in eyes with co-existing corneal conditions or surgically altered corneas.Recent findings: Careful consideration and selection is required in patients with co-existing corneal conditions who desire spectacle independence. Presbyopia-correcting IOLs have been shown to be safe and provide good uncorrected vision in eyes with previous CRS. Modern biometry formulas have improved predictability in eyes with previous CRS, though evidence related to presbyopia-correcting IOLs is limited. Pinhole IOLs may be suitable for eyes with irregular/aberrated corneas. Further evidence regarding presbyopia-correcting IOLs is required in eyes with dry eye disease, keratoconus, and corneal graft. Knowledge of the range of available IOLs are key to optimizing visual quality and achieving spectacle independence.Summary: Patients with prior CRS or co-existing corneal disease(s) present unique challenges when considering presbyopia-correcting IOLs. While promising options are available, successful outcomes depend on careful patient selection, thorough corneal assessment, and realistic management of patient expectations.","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":" ","pages":""},"PeriodicalIF":2.6000,"publicationDate":"2025-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Opinion in Ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/ICU.0000000000001175","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose of review: Modern presbyopia-correcting intraocular lenses (IOLs) offer a potential solution to address the rising postoperative demand and expectations for spectacle independence following cataract surgery. However, IOL calculation and selection becomes more complex when presented with previous corneal refractive surgery (CRS) or co-existing corneal conditions. This review explores the use of presbyopia-correcting IOLs in eyes with co-existing corneal conditions or surgically altered corneas.

Recent findings: Careful consideration and selection is required in patients with co-existing corneal conditions who desire spectacle independence. Presbyopia-correcting IOLs have been shown to be safe and provide good uncorrected vision in eyes with previous CRS. Modern biometry formulas have improved predictability in eyes with previous CRS, though evidence related to presbyopia-correcting IOLs is limited. Pinhole IOLs may be suitable for eyes with irregular/aberrated corneas. Further evidence regarding presbyopia-correcting IOLs is required in eyes with dry eye disease, keratoconus, and corneal graft. Knowledge of the range of available IOLs are key to optimizing visual quality and achieving spectacle independence.

Summary: Patients with prior CRS or co-existing corneal disease(s) present unique challenges when considering presbyopia-correcting IOLs. While promising options are available, successful outcomes depend on careful patient selection, thorough corneal assessment, and realistic management of patient expectations.

查看原文本刊更多论文

有角膜状况的眼睛中的老花眼矫正人工晶状体：最新进展。

回顾目的：现代老花眼矫正人工晶状体（iol）提供了一个潜在的解决方案，以满足白内障手术后对眼镜独立性的需求和期望。然而，当存在既往角膜屈光手术（CRS）或并存角膜疾病时，人工晶状体的计算和选择变得更加复杂。本综述探讨了老花眼矫正人工晶状体在并存角膜疾病或手术改变角膜中的应用。最近的研究发现：对于希望独立佩戴眼镜的并存角膜疾病患者，需要仔细考虑和选择。老花眼矫正人工晶状体已被证明是安全的，并提供良好的未矫正视力的眼睛以前的CRS。现代生物计量公式提高了先前CRS眼睛的可预测性，尽管与老花眼矫正iol相关的证据有限。针孔人工晶状体可能适用于角膜不规则/畸变的眼睛。对于干眼病、圆锥角膜和角膜移植的眼睛，需要进一步的证据来证明老花眼矫正人工晶状体。了解可用iol的范围是优化视觉质量和实现眼镜独立性的关键。总结：既往有CRS或并存角膜疾病的患者在考虑老花眼矫正人工晶状体时面临着独特的挑战。虽然有希望的选择是可用的，但成功的结果取决于仔细的患者选择，彻底的角膜评估，以及对患者期望的现实管理。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current Opinion in Ophthalmology 医学-眼科学

CiteScore

6.80

自引率

5.40%

发文量

120

审稿时长

6-12 weeks

期刊介绍： Current Opinion in Ophthalmology is an indispensable resource featuring key up-to-date and important advances in the field from around the world. With renowned guest editors for each section, every bimonthly issue of Current Opinion in Ophthalmology delivers a fresh insight into topics such as glaucoma, refractive surgery and corneal and external disorders. With ten sections in total, the journal provides a convenient and thorough review of the field and will be of interest to researchers, clinicians and other healthcare professionals alike.